Ishanu Chattopadhyay PRO
ML | Data Science Biomedical Informatics | Social Science | Assistant Professor
Zero-burden Risk Assessment for Test-free Screening &
Predictive Prognosis of Alzheimer's Disease & Mild Cognitive Impairment
Ishanu Chattopadhyay, PhD
Assistant Professor of Internal Medicine
Institute of Biomedical Informatics
& Computer Science
University of Kentucky
Zero Knowledge Discovery
Zero-Burden Co-morbid Risk Score
Reduce screen failue rate
ASD
ADRD
IPF
ZCoR
Diagnostic procedural codes & prescriptions
ICD
Explainable glassbox Visualizations
+
Universal Point-of-care Screening
Enable early diagnosis
Target PF/IPF or ILDs broadly
Seamless background integration with EHR/clinical workflows
Technology Overview
2. Conventional AI attempts to model the physician
Current State of Art
1. Use of AI in point-of-care diagnostic workflow is limited
ZCoR
*Chattopadhyay, Ishanu, and Hod Lipson. "Abductive learning of quantized stochastic processes with probabilistic finite automata." Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences 371, no. 1984 (2013): 20110543.
Curated Disease-agnostic Features | Odds ratio dictionaries combined with multi-stage LGBMs | Specialized HMM based Longitudinal Tracking*
Most predictive AI platforms, including those from Merative, PathAI, Tempus, Google Health, and Microsoft, primarily rely on imaging data for early detection.
State of the art screening approaches are inadequate
Standard AI
ZCoR | Competition | |
---|---|---|
Autism | >83% | "obvious" |
Alzheimer's Disease | ~90% | 60-70% |
Idiopathic Pulmonary Fibrosis | ~90% | NA |
MACE | ~80% | ~70% |
Bipolar Disorder | ~85% | NA |
CKD | ~85% | NA |
Rare Cancers (Bladder, Uterus) | ~75-80% | Low |
Suicidality (with CAT-SS) | 98% PPV | Low |
Validation
CELL Reports
Performance comparison with Li et al.*
*Li, Qian, Xi Yang, Jie Xu, Yi Guo, Xing He, Hui Hu, Tianchen Lyu et al. "Early prediction of Alzheimer's disease and related dementias using real‐world electronic health records." Alzheimer's & Dementia 19, no. 8 (2023): 3506-3518
dddd
d
d
d
d
d
d
ZCoR Screening
Performance
Screening performance over time
Prospective Pilot at UCM
MOCA
ZCoR
SHAP Values for Male True Positive patients
By Ishanu Chattopadhyay
ML | Data Science Biomedical Informatics | Social Science | Assistant Professor